99mTc-3PRGDcintimammography in palpable and nonpalpable breast lesions

Molecular Imaging

Volumn 13, Issue 5, 2014, Pages

  Liu, Lin ^a   Song, Yan ^a   Gao, Shi ^a   Ji, Tiefeng ^a   Zhang, Haishan ^a   Ji, Bin ^a   Chen, Ben ^a   Jia, Bing ^a   Wang, Fan ^a   Xu, Zheli ^a   Ma, Qingjie ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASES; MAMMOGRAPHY; NUCLEAR MEDICINE; POLYETHYLENE GLYCOLS;

BREAST CANCER DETECTION; BREAST IMAGING REPORTING AND DATA SYSTEMS; DIAGNOSTIC PERFORMANCE; IMMUNOHISTOCHEMISTRY; NEGATIVE PREDICTIVE VALUE; NONPALPABLE BREAST LESIONS; POSITIVE PREDICTIVE VALUES; SCINTIGRAPHIC IMAGES;

MEDICAL IMAGING;

EID: 84905821736     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2014.00010     Document Type: Article

References (24)

1. Desantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:52-62, doi:10.3322/caac.21203
2. Sondik EJ. Breast cancer trends. Incidence, mortality, and survival. Cancer 1994;74:995-9, doi:10.1002/1097-0142(19940801)74:3+<995::AID- CNCR2820741504.3.0.CO;2-M
3. Garfinkel L, Boring CC, Heath CW Jr. Changing trends. An overview of breast cancer incidence and mortality. Cancer 1994;74: 222-7, doi:10.1002/cncr.2820741304
4. Murphy IG, Dillon MF, Doherty AO, et al. Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 2007;96:457-63, doi:10.1002/jso.20801
5. Kopans DB. The positive predictive value of mammography. AJR Am J Roentgenol 1992;158:521-6, doi:10.2214/ajr.158.3.1310825
6. Liberman M, Sampalis F, Mulder DS, et al. Breast cancer diagnosis by scintimammography: A meta-Analysis and review of the literature. Breast Cancer Res Treat 2003;80:115-26, doi:10.1023/A:1024417331304
7. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: A new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994;21:357-62, doi:10.1007/BF00947973
8. Hussain R, Buscombe JR. A meta-Analysis of scintimammography: An evidence-Based approach to its clinical utility. Nucl Med Commun 2006;27:589-94, doi:10.1097/00006231-200607000-00007
9. Tiling R, Tatsch K, Sommer H, et al. Technetium-99m-Sestamibi scintimammography for the detection of breast carcinoma: Comparison between planar and SPECT imaging. J Nucl Med 1998;39:849-56
10. Niu G, Chen X. Why integrin as a primary target for imaging and therapy. Theranostics 2011;1:30-47, doi:10.7150/thno/v01p0030
11. Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10:9-22, doi:10.1038/nrc2748
12. Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 2008;49 Suppl 2:113S-28S, doi:10.2967/jnumed.107.045922
13. Chen X. Multimodality imaging of tumor integrin alphavbeta3 expression. Mini Rev Med Chem 2006;6:227-34, doi:10.2174/138955706775475975
14. Dimastromatteo J, Riou LM, Ahmadi M, et al. In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-Targeted tracer 99mTc-RAFT-RGD. J Nucl Cardiol 2010; 17:435-43, doi:10.1007/s12350-010-9191-9
15. Myers TA, Kaushal D, Philipp MT. Microglia are mediators of Borrelia burgdorferi-Induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog 2009;5:e1000659, doi:10.1371/journal.ppat.1000659
16. Wang L, Shi J, Kim YS, et al. Improving tumor-Targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Mol Pharm 2009;6:231-45, doi:10.1021/mp800150r
17. Ma Q, Ji B, Jia B, et al. Differential diagnosis of solitary pulmonary nodules using (9)(9)mTc-3P(4)-RGD(2) scintigraphy. Eur J Nucl Med Mol Imaging 2011;38:2145-52, doi:10.1007/s00259-011-1901-2
18. - 1990 recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21:1-201
19. Sasajima T, Shimada N, Naitoh Y, et al. (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors. Int J Cancer 2007;121:2637-45, doi:10.1002/ijc.23011
20. Palmedo H, Schomburg A, Grunwald F, et al. Technetium-99m- MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-30
21. Mekhmandarov S, Sandbank J, Cohen M, et al. Technetium-99m- MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med 1998;39:86-91
22. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18, doi:10.1146/annurev. med.57.121304.131306
23. Xu HB, Li L, Xu Q. Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: Meta-Analysis and meta-regression. Nucl Med Commun 2011;32:980-8, doi:10.1097/MNM.0b013e 32834b43a9
24. Mousa SA. alphav Vitronectin receptors in vascular-mediated disorders. Med Res Rev 2003;23:190-9, doi:10.1002/med.10031